Safety and Efficacy Study of BETOPTIC S 0.25% and Timolol Gel-forming Solution 0.25% and 0.5% in Pediatric Patients With Glaucoma or Ocular Hypertension
Completed · Phase 3
Conditions studied: Glaucoma, Ocular Hypertension
In brief
The purpose of this study is to evaluate the safety and efficacy of BETOPTIC S and Timolol Gel-forming solution in pediatric patients. Patients will dose with study drug at 8 am and 8 pm daily for twelve weeks. Patients will have vision tested, slit lamp exam, blood pressure and pulse checks at each visit. Patients will have a dilated fundus exam and corneal measurements taken at first and last visit.
Key facts
- Study ID
- NCT00061542
- Run by
- Alcon Research
- People needed
- 105
- Starts
- 2003-01-01
- Expected to finish
- 2006-11-01
- Last updated by the study team
- 2016-11-18
Who can join
Age: 0 and older, up to 5. Sex: male. Healthy volunteers: not accepted.
Where it is running
- Alcon Call Center — Fort Worth, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.